Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2 across the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 from the page; no other content changes were observed.SummaryDifference0.0%

- Check70 days agoChange DetectedUI text updates include showing the glossary, capitalization changes in QC-related labels, and FEAR Act data and revision notes. These changes do not affect the study details, eligibility criteria, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 on the page.SummaryDifference0.0%

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.